3020 South Tech Boulevard
12 articles with Riverain Technologies
ClearRead CT is an FDA-Cleared, Patent-Protected, Deep Learning Radiology Solution.
Riverain Technologies announced today that the United States Patent and Trademark Office has awarded the company a broad patent for its technology that forms a vessel suppressed, chest CT series using deep learning and synthetic data modeling.
The study documents the results of a multi-reader, multi-case, blinded reader study that shows the benefits of ClearRead CT both in terms of improved reading efficiency and reading accuracy.
Riverain’s ClearRead CT install base has expanded in the U.S. as leading institutions see the value in its efficient and effective detection of lung nodules across all chest CTs, including lung cancer screening exams.
Study Shows Riverain Technologies Chest X-Ray CAD Detects Previously Missed Lung Cancers 18 Months Earlier
Riverain Technologies’s ClearRead Applications Gain Popularity, Demonstrating 36 Percent Growth In Adoption Year Over Year